[CYCC] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -450.17%
YoY- -164.76%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 356 396 299 309 264 212 5 1631.32%
PBT -5,635 -5,446 -4,026 -5,746 1,248 -3,356 -5,067 7.36%
Tax -816 -569 -452 -730 -230 -258 -637 18.00%
NP -4,812 -4,869 -3,559 -5,004 1,429 -3,082 -4,764 0.67%
Tax Rate - - - - 18.43% - - -
Total Cost 5,168 5,265 3,858 5,313 -1,165 3,294 4,769 5.51%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -1,351.69 -1,229.55 -1,190.30 -1,619.42 541.29 -1,453.77 -95,280.00 -94.18%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -51.14 -59.83 -44.87 -67.51 24.00 -75.55 -149.01 -51.07%
EPS Diluted -51.14 -59.83 -44.87 -67.51 24.00 -75.55 -149.01 -51.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.